{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:33:26Z","timestamp":1768736006572,"version":"3.49.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD083026"],"award-info":[{"award-number":["R01HD083026"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196043","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T17:42:39Z","timestamp":1524764559000},"page":"e0196043","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4\/CD8 ratios and CCR5 levels"],"prefix":"10.1371","volume":"13","author":[{"given":"Michelle F.","family":"Maritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn M.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis J.","family":"Bick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Tomasicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Woodland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashini","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanel","family":"Avenant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-4861","authenticated-orcid":true,"given":"Janet P.","family":"Hapgood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women","volume":"30","author":"CB Polis","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e1001778","DOI":"10.1371\/journal.pmed.1001778","article-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis","volume":"12","author":"CS Morrison","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/GCO.0000000000000228","article-title":"Hormonal contraceptive use and women\u2019s risk of HIV acquisition: priorities emerging from recent data","volume":"27","author":"LJ Ralph","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","article-title":"Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk","volume":"27","author":"AR Butler","year":"2013","journal-title":"AIDS"},{"key":"ref5","unstructured":"ECHO. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/echo-consortium.com\/\" xlink:type=\"simple\">http:\/\/echo-consortium.com\/<\/ext-link>."},{"key":"ref6","unstructured":"World Health Organisation. Hormonal contraceptive eligibility for women at high risk of HIV. Guidance Statement: Recommendations concerning the use of hormonal contraceptive methods by women at high risk of HIV. Geneva, Switzerland: World Health Organisation; 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/254662\/1\/WHO-RHR-17.04-eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/254662\/1\/WHO-RHR-17.04-eng.pdf<\/ext-link>."},{"key":"ref7","article-title":"Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women\u2019s risk of HIV?","author":"CB Polis","year":"2017","journal-title":"Contraception"},{"key":"ref8","article-title":"Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms","author":"JP Hapgood","year":"2017","journal-title":"Endocr Rev"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4049\/immunohorizons.1700047","article-title":"Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4(+) T-cells to HIV infection","volume":"1","author":"C Tasker","year":"2017","journal-title":"Immunohorizons"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","article-title":"Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction","volume":"299","author":"K Ronacher","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"ref11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"D Koubovec","year":"2005","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"e96497","DOI":"10.1371\/journal.pone.0096497","article-title":"The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor","volume":"9","author":"Y Govender","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/aji.12214","article-title":"Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis","volume":"71","author":"JP Hapgood","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"e62895","DOI":"10.1371\/journal.pone.0062895","article-title":"The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor","volume":"8","author":"M Tomasicchio","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2014.02.006","article-title":"Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs","volume":"90","author":"RP Huijbregts","year":"2014","journal-title":"Contraception"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/en.2012-1850","article-title":"Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms","volume":"154","author":"RP Huijbregts","year":"2013","journal-title":"Endocrinology"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0000000000000681","article-title":"Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro","volume":"29","author":"ME Sampah","year":"2015","journal-title":"AIDS"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.4049\/jimmunol.162.12.7510","article-title":"Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro","volume":"162","author":"N Vassiliadou","year":"1999","journal-title":"J Immunol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"D Africander","year":"2011","journal-title":"Steroids"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"FZ Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"JP Hapgood","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"10\u201313","key":"ref22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"FZ Stanczyk","year":"2003","journal-title":"Steroids"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"D Africander","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"DJ Africander","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2013.08.001","article-title":"Potency of progestogens used in hormonal therapy: toward understanding differential actions","volume":"142","author":"JP Hapgood","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"e24639","DOI":"10.1371\/journal.pone.0024639","article-title":"Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users","volume":"6","author":"L Kleynhans","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"ref27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2004.03.006","article-title":"Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells","volume":"221","author":"D Koubovec","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"45","key":"ref28","doi-asserted-by":"crossref","first-page":"31136","DOI":"10.1074\/jbc.M114.587311","article-title":"Medroxyprogesterone Acetate Differentially Regulates Interleukin (IL)-12 and IL-10 in a Human Ectocervical Epithelial Cell Line in a Glucocorticoid Receptor (GR)-dependent Manner","volume":"289","author":"R Louw-du Toit","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.08.028","article-title":"Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC","volume":"408","author":"TG Edmonds","year":"2010","journal-title":"Virology"},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"WS Pear","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref31","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.4081\/idr.2011.2370","article-title":"Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants","volume":"3","author":"SK Eszterhas","year":"2011","journal-title":"Infect Dis Rep"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"19297","DOI":"10.1074\/jbc.M110.193672","article-title":"Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response","volume":"286","author":"NJ Verhoog","year":"2011","journal-title":"J Biol Chem"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/bi901956s","article-title":"Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment","volume":"49","author":"C Avenant","year":"2010","journal-title":"Biochemistry"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375","author":"VR Polonis","year":"2008","journal-title":"Virology"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera","volume":"70","author":"J Jain","year":"2004","journal-title":"Contraception"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.clinthera.2004.11.013","article-title":"Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg\/0.65 mL) contraceptive formulation in Asian women","volume":"26","author":"YC Toh","year":"2004","journal-title":"Clin Ther"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0015-0282(16)44895-8","article-title":"A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate","volume":"34","author":"K Fotherby","year":"1980","journal-title":"Fertil Steril"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0010-7824(81)90065-2","article-title":"Pharmacokinetics of norethisterone oenanthate in humans","volume":"24","author":"GW Sang","year":"1981","journal-title":"Contraception"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts","volume":"5","author":"AT Haase","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/j.1460-2075.1990.tb08274.x","article-title":"HIV-1 replication is controlled at the level of T cell activation and proviral integration","volume":"9","author":"M Stevenson","year":"1990","journal-title":"EMBO J"},{"issue":"19","key":"ref43","doi-asserted-by":"crossref","first-page":"10189","DOI":"10.1128\/JVI.02529-10","article-title":"HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo","volume":"85","author":"AL Meditz","year":"2011","journal-title":"J Virol"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","article-title":"Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study","volume":"16","author":"EH Byrne","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"e0178193","DOI":"10.1371\/journal.pone.0178193","article-title":"Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women","volume":"12","author":"SS Iyer","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/jiv233","article-title":"CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception","volume":"212","author":"G Sciaranghella","year":"2015","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"ref47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-0378(01)00125-5","article-title":"Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women","volume":"54","author":"M Prakash","year":"2002","journal-title":"J Reprod Immunol"},{"issue":"8","key":"ref48","first-page":"479","article-title":"Decreased suppressor T-lymphocytes in women who received progestogen injections","volume":"75","author":"V Sridama","year":"1992","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"ref49","first-page":"421","article-title":"Effect of hormone replacement therapy on CD4+ and CD8+ numbers, CD4+\/CD8+ ratio, and immunoglobulin levels in hemodialysis patients","volume":"27","author":"E Dogan","year":"2005","journal-title":"Ren Fail"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/humrep\/dev035","article-title":"Medroxyprogesterone acetate impairs human dendritic cell activation and function","volume":"30","author":"NE Quispe Calla","year":"2015","journal-title":"Hum Reprod"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"EJ Platt","year":"1998","journal-title":"J Virol"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/molehr\/gau063","article-title":"CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma","volume":"20","author":"KJ Sales","year":"2014","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","article-title":"Effect of hormonal contraceptive methods on HIV disease progression: a systematic review","volume":"27","author":"SJ Phillips","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2015.10.002","article-title":"The safety of hormonal contraceptives for women living with HIV and their sexual partners","volume":"93","author":"SJ Phillips","year":"2016","journal-title":"Contraception"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAD.0b013e32835ad473","article-title":"Hormonal contraceptive use and risk of HIV-1 disease progression","volume":"27","author":"R Heffron","year":"2013","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T09:06:52Z","timestamp":1693645612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196043"}},"subtitle":[],"editor":[{"given":"Srinivas","family":"Mummidi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196043","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}